PDB Short entry for 3BPT HEADER HYDROLASE 19-DEC-07 3BPT TITLE CRYSTAL STRUCTURE OF HUMAN BETA-HYDROXYISOBUTYRYL-COA HYDROLASE IN TITLE 2 COMPLEX WITH QUERCETIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3-HYDROXYISOBUTYRYL-COA HYDROLASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 32-386; COMPND 5 SYNONYM: 3-HYDROXYISOBUTYRYL-COENZYME A HYDROLASE, HIBYL-COA-H, HIB- COMPND 6 COA HYDROLASE; COMPND 7 EC: 3.1.2.4; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HIBCH; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: B834(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PNIC-CTHF KEYWDS COENZYME A, HYDROLASE, BETA-HYDROXYISOBUTYRYL ACID, QUERCETIN, KEYWDS 2 STRUCTURAL GENOMICS CONSORTIUM, SGC, BRANCHED-CHAIN AMINO ACID KEYWDS 3 CATABOLISM, DISEASE MUTATION, MITOCHONDRION, TRANSIT PEPTIDE EXPDTA X-RAY DIFFRACTION AUTHOR E.S.PILKA,C.PHILLIPS,O.N.F.KING,K.GUO,F.VON DELFT,A.C.W.PIKE, AUTHOR 2 C.H.ARROWSMITH,J.WEIGELT,A.M.EDWARDS,U.OPPERMANN,STRUCTURAL GENOMICS AUTHOR 3 CONSORTIUM (SGC) REVDAT 4 25-OCT-17 3BPT 1 REMARK REVDAT 3 13-JUL-11 3BPT 1 VERSN REVDAT 2 24-FEB-09 3BPT 1 VERSN REVDAT 1 08-JAN-08 3BPT 0 JRNL AUTH E.S.PILKA,C.PHILLIPS,O.N.F.KING,K.GUO,F.VON DELFT, JRNL AUTH 2 A.C.W.PIKE,C.H.ARROWSMITH,J.WEIGELT,A.M.EDWARDS,U.OPPERMANN JRNL TITL CRYSTAL STRUCTURE OF HUMAN BETA-HYDROXYISOBUTYRYL-COA JRNL TITL 2 HYDROLASE IN COMPLEX WITH QUERCETIN. JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.4.0066 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 31.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 83.3 REMARK 3 NUMBER OF REFLECTIONS : 44613 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.149 REMARK 3 R VALUE (WORKING SET) : 0.147 REMARK 3 FREE R VALUE : 0.197 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2334 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.54 REMARK 3 REFLECTION IN BIN (WORKING SET) : 888 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 22.27 REMARK 3 BIN R VALUE (WORKING SET) : 0.2330 REMARK 3 BIN FREE R VALUE SET COUNT : 37 REMARK 3 BIN FREE R VALUE : 0.3510 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2803 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 29 REMARK 3 SOLVENT ATOMS : 587 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 10.64 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.38000 REMARK 3 B22 (A**2) : -0.18000 REMARK 3 B33 (A**2) : -0.75000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.87000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.080 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.089 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.052 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.741 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.970 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.950 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2934 ; 0.018 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1985 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3971 ; 1.594 ; 1.983 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4867 ; 0.981 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 366 ; 5.823 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 130 ;33.219 ;24.769 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 524 ;12.045 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 15 ;12.581 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 446 ; 0.099 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3257 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 577 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1809 ; 2.469 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 742 ; 0.822 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2914 ; 3.584 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1125 ; 5.819 ; 7.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1051 ; 8.108 ;11.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 32 A 393 REMARK 3 ORIGIN FOR THE GROUP (A): 36.7799 -7.8921 14.6141 REMARK 3 T TENSOR REMARK 3 T11: -0.0331 T22: -0.0313 REMARK 3 T33: -0.0244 T12: 0.0000 REMARK 3 T13: -0.0009 T23: 0.0004 REMARK 3 L TENSOR REMARK 3 L11: 0.4265 L22: 0.5405 REMARK 3 L33: 0.4643 L12: -0.0522 REMARK 3 L13: 0.0173 L23: 0.0143 REMARK 3 S TENSOR REMARK 3 S11: -0.0168 S12: -0.0079 S13: 0.0108 REMARK 3 S21: 0.0047 S22: 0.0051 S23: -0.0107 REMARK 3 S31: -0.0176 S32: 0.0193 S33: 0.0117 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.00 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3BPT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-DEC-07. REMARK 100 THE DEPOSITION ID IS D_1000045816. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-DEC-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97912 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 44613 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 31.050 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 83.3 REMARK 200 DATA REDUNDANCY : 6.600 REMARK 200 R MERGE (I) : 0.07300 REMARK 200 R SYM (I) : 0.04400 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 17.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.58 REMARK 200 COMPLETENESS FOR SHELL (%) : 31.8 REMARK 200 DATA REDUNDANCY IN SHELL : 2.20 REMARK 200 R MERGE FOR SHELL (I) : 0.37700 REMARK 200 R SYM FOR SHELL (I) : 0.35600 REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: SHELXD REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.57 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.18 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M CITRATE PH 5.5, 20% PEG 3350, 5MM REMARK 280 QUERCETIN ADDED TO THE PROTEIN, MATRIX SEEDING, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 38.32100 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MSE A 31 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 43 CD CE NZ REMARK 470 LYS A 92 CD CE NZ REMARK 470 LYS A 162 CE NZ REMARK 470 LYS A 233 CE NZ REMARK 470 LYS A 237 CE NZ REMARK 470 LYS A 257 CE NZ REMARK 470 LYS A 297 NZ REMARK 470 LYS A 353 NZ REMARK 470 GLN A 355 CD OE1 NE2 REMARK 470 LYS A 358 CD CE NZ REMARK 470 LYS A 360 CD CE NZ REMARK 470 LYS A 377 CE NZ REMARK 470 LYS A 385 CD CE NZ REMARK 470 GLU A 388 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CG MSE A 123 O HOH A 692 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 109 -153.57 -133.54 REMARK 500 SER A 151 -54.63 -126.15 REMARK 500 LEU A 174 -138.17 -116.87 REMARK 500 ASP A 177 -147.87 -88.61 REMARK 500 ILE A 351 -63.30 -98.75 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 PROTEIN WAS CO-CRYSTALLIZED WITH THE PRO-DRUG QUERCETIN, REMARK 600 UNDERGOING FAST HYDROLYSIS IN SOLUTION (P.J. MULHOLLAND REMARK 600 ET AL., 2001). THE LIGAND DENSITY WAS MODELLED AS QUERCETIN, REMARK 600 AN EXTRA DENSITY PRESENT ABOVE THE C17 HYDROXYL GROUP IS REMARK 600 INCONSISTENT WITH THE PRO-DRUG STRUCTURE PUBLISHED AND WAS REMARK 600 NOT MODELLED. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE QUE A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HIU A 502 DBREF 3BPT A 32 386 UNP Q6NVY1 HIBCH_HUMAN 32 386 SEQADV 3BPT MSE A 31 UNP Q6NVY1 EXPRESSION TAG SEQADV 3BPT GLY A 41 UNP Q6NVY1 GLU 41 CONFLICT SEQADV 3BPT ALA A 387 UNP Q6NVY1 EXPRESSION TAG SEQADV 3BPT GLU A 388 UNP Q6NVY1 EXPRESSION TAG SEQADV 3BPT ASN A 389 UNP Q6NVY1 EXPRESSION TAG SEQADV 3BPT LEU A 390 UNP Q6NVY1 EXPRESSION TAG SEQADV 3BPT TYR A 391 UNP Q6NVY1 EXPRESSION TAG SEQADV 3BPT PHE A 392 UNP Q6NVY1 EXPRESSION TAG SEQADV 3BPT GLN A 393 UNP Q6NVY1 EXPRESSION TAG SEQRES 1 A 363 MSE THR ASP ALA ALA GLU GLU VAL LEU LEU GLY LYS LYS SEQRES 2 A 363 GLY CYS THR GLY VAL ILE THR LEU ASN ARG PRO LYS PHE SEQRES 3 A 363 LEU ASN ALA LEU THR LEU ASN MSE ILE ARG GLN ILE TYR SEQRES 4 A 363 PRO GLN LEU LYS LYS TRP GLU GLN ASP PRO GLU THR PHE SEQRES 5 A 363 LEU ILE ILE ILE LYS GLY ALA GLY GLY LYS ALA PHE CYS SEQRES 6 A 363 ALA GLY GLY ASP ILE ARG VAL ILE SER GLU ALA GLU LYS SEQRES 7 A 363 ALA LYS GLN LYS ILE ALA PRO VAL PHE PHE ARG GLU GLU SEQRES 8 A 363 TYR MSE LEU ASN ASN ALA VAL GLY SER CYS GLN LYS PRO SEQRES 9 A 363 TYR VAL ALA LEU ILE HIS GLY ILE THR MSE GLY GLY GLY SEQRES 10 A 363 VAL GLY LEU SER VAL HIS GLY GLN PHE ARG VAL ALA THR SEQRES 11 A 363 GLU LYS CYS LEU PHE ALA MSE PRO GLU THR ALA ILE GLY SEQRES 12 A 363 LEU PHE PRO ASP VAL GLY GLY GLY TYR PHE LEU PRO ARG SEQRES 13 A 363 LEU GLN GLY LYS LEU GLY TYR PHE LEU ALA LEU THR GLY SEQRES 14 A 363 PHE ARG LEU LYS GLY ARG ASP VAL TYR ARG ALA GLY ILE SEQRES 15 A 363 ALA THR HIS PHE VAL ASP SER GLU LYS LEU ALA MSE LEU SEQRES 16 A 363 GLU GLU ASP LEU LEU ALA LEU LYS SER PRO SER LYS GLU SEQRES 17 A 363 ASN ILE ALA SER VAL LEU GLU ASN TYR HIS THR GLU SER SEQRES 18 A 363 LYS ILE ASP ARG ASP LYS SER PHE ILE LEU GLU GLU HIS SEQRES 19 A 363 MSE ASP LYS ILE ASN SER CYS PHE SER ALA ASN THR VAL SEQRES 20 A 363 GLU GLU ILE ILE GLU ASN LEU GLN GLN ASP GLY SER SER SEQRES 21 A 363 PHE ALA LEU GLU GLN LEU LYS VAL ILE ASN LYS MSE SER SEQRES 22 A 363 PRO THR SER LEU LYS ILE THR LEU ARG GLN LEU MSE GLU SEQRES 23 A 363 GLY SER SER LYS THR LEU GLN GLU VAL LEU THR MSE GLU SEQRES 24 A 363 TYR ARG LEU SER GLN ALA CYS MSE ARG GLY HIS ASP PHE SEQRES 25 A 363 HIS GLU GLY VAL ARG ALA VAL LEU ILE ASP LYS ASP GLN SEQRES 26 A 363 SER PRO LYS TRP LYS PRO ALA ASP LEU LYS GLU VAL THR SEQRES 27 A 363 GLU GLU ASP LEU ASN ASN HIS PHE LYS SER LEU GLY SER SEQRES 28 A 363 SER ASP LEU LYS PHE ALA GLU ASN LEU TYR PHE GLN MODRES 3BPT MSE A 64 MET SELENOMETHIONINE MODRES 3BPT MSE A 123 MET SELENOMETHIONINE MODRES 3BPT MSE A 144 MET SELENOMETHIONINE MODRES 3BPT MSE A 167 MET SELENOMETHIONINE MODRES 3BPT MSE A 224 MET SELENOMETHIONINE MODRES 3BPT MSE A 265 MET SELENOMETHIONINE MODRES 3BPT MSE A 302 MET SELENOMETHIONINE MODRES 3BPT MSE A 315 MET SELENOMETHIONINE MODRES 3BPT MSE A 328 MET SELENOMETHIONINE MODRES 3BPT MSE A 337 MET SELENOMETHIONINE HET MSE A 64 8 HET MSE A 123 8 HET MSE A 144 8 HET MSE A 167 8 HET MSE A 224 8 HET MSE A 265 8 HET MSE A 302 8 HET MSE A 315 8 HET MSE A 328 8 HET MSE A 337 8 HET QUE A 501 27 HET HIU A 502 7 HETNAM MSE SELENOMETHIONINE HETNAM QUE 3,5,7,3',4'-PENTAHYDROXYFLAVONE HETNAM HIU (2R)-3-HYDROXY-2-METHYLPROPANOIC ACID HETSYN QUE QUERCETIN HETSYN HIU 3-HYDROXYISOBUTYRATE FORMUL 1 MSE 10(C5 H11 N O2 SE) FORMUL 2 QUE C15 H10 O7 FORMUL 3 HIU C4 H8 O3 FORMUL 4 HOH *587(H2 O) HELIX 1 1 ARG A 53 LEU A 57 5 5 HELIX 2 2 THR A 61 ASP A 78 1 18 HELIX 3 3 ASP A 99 LYS A 108 1 10 HELIX 4 4 ILE A 113 SER A 130 1 18 HELIX 5 5 GLY A 145 LEU A 150 1 6 HELIX 6 6 PRO A 168 ILE A 172 5 5 HELIX 7 7 GLY A 179 LEU A 187 1 9 HELIX 8 8 LYS A 190 GLY A 199 1 10 HELIX 9 9 GLY A 204 ALA A 210 1 7 HELIX 10 10 ASP A 218 GLU A 220 5 3 HELIX 11 11 LYS A 221 LEU A 232 1 12 HELIX 12 12 SER A 236 SER A 251 1 16 HELIX 13 13 LEU A 261 GLU A 263 5 3 HELIX 14 14 HIS A 264 PHE A 272 1 9 HELIX 15 15 THR A 276 GLY A 288 1 13 HELIX 16 16 SER A 289 ASN A 300 1 12 HELIX 17 17 SER A 303 SER A 318 1 16 HELIX 18 18 THR A 321 ARG A 338 1 18 HELIX 19 19 HIS A 340 LEU A 350 1 11 HELIX 20 20 ASP A 363 VAL A 367 5 5 HELIX 21 21 THR A 368 LYS A 377 1 10 HELIX 22 22 LEU A 379 ASP A 383 5 5 HELIX 23 23 GLU A 388 PHE A 392 5 5 SHEET 1 A 6 VAL A 38 LYS A 43 0 SHEET 2 A 6 THR A 46 LEU A 51 -1 O VAL A 48 N GLY A 41 SHEET 3 A 6 LEU A 83 GLY A 88 1 O ILE A 85 N ILE A 49 SHEET 4 A 6 TYR A 135 ILE A 139 1 O LEU A 138 N ILE A 86 SHEET 5 A 6 PHE A 156 ALA A 159 1 O VAL A 158 N ALA A 137 SHEET 6 A 6 HIS A 215 PHE A 216 1 O HIS A 215 N ALA A 159 SHEET 1 B 4 ALA A 93 CYS A 95 0 SHEET 2 B 4 ILE A 142 MSE A 144 1 O MSE A 144 N CYS A 95 SHEET 3 B 4 LEU A 164 ALA A 166 1 O LEU A 164 N THR A 143 SHEET 4 B 4 LEU A 202 LYS A 203 -1 O LEU A 202 N PHE A 165 LINK C ASN A 63 N MSE A 64 1555 1555 1.34 LINK C MSE A 64 N ILE A 65 1555 1555 1.33 LINK C TYR A 122 N MSE A 123 1555 1555 1.33 LINK C MSE A 123 N LEU A 124 1555 1555 1.34 LINK C THR A 143 N MSE A 144 1555 1555 1.34 LINK C MSE A 144 N GLY A 145 1555 1555 1.32 LINK C ALA A 166 N MSE A 167 1555 1555 1.33 LINK C MSE A 167 N PRO A 168 1555 1555 1.33 LINK C ALA A 223 N MSE A 224 1555 1555 1.33 LINK C MSE A 224 N LEU A 225 1555 1555 1.33 LINK C HIS A 264 N MSE A 265 1555 1555 1.33 LINK C MSE A 265 N ASP A 266 1555 1555 1.33 LINK C LYS A 301 N MSE A 302 1555 1555 1.32 LINK C MSE A 302 N SER A 303 1555 1555 1.34 LINK C LEU A 314 N MSE A 315 1555 1555 1.33 LINK C MSE A 315 N GLU A 316 1555 1555 1.33 LINK C THR A 327 N MSE A 328 1555 1555 1.32 LINK C MSE A 328 N GLU A 329 1555 1555 1.32 LINK C CYS A 336 N MSE A 337 1555 1555 1.32 LINK C MSE A 337 N ARG A 338 1555 1555 1.33 CISPEP 1 LYS A 360 PRO A 361 0 -1.54 SITE 1 AC1 13 PHE A 56 LEU A 57 ALA A 59 GLY A 97 SITE 2 AC1 13 GLY A 98 ILE A 100 PRO A 168 ILE A 172 SITE 3 AC1 13 VAL A 349 LEU A 350 HIU A 502 HOH A 886 SITE 4 AC1 13 HOH A 924 SITE 1 AC2 11 GLY A 97 GLY A 98 ILE A 100 PHE A 118 SITE 2 AC2 11 GLU A 121 GLY A 146 GLU A 169 LEU A 174 SITE 3 AC2 11 ASP A 177 VAL A 178 QUE A 501 CRYST1 44.096 76.642 55.789 90.00 108.24 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022678 0.000000 0.007475 0.00000 SCALE2 0.000000 0.013048 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018873 0.00000